Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probing inhibitor-induced conformational changes along the interface between tissue factor and factor VIIa.

M Osterlund1, R Owenius, K Carlsson

  • 1IFM-Department of Chemistry, Linköping University, Linköping, Sweden.

Biochemistry
|August 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey: comment.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Assessment of dosimetric impact of system specific geometric distortion in an MRI only based radiotherapy workflow for prostate.

Physics in medicine and biology·2017
Same author

Dose related effects of LPS on endometrial epithelial cell populations from dioestrus cows.

Animal reproduction science·2016
Same author

Low degree of satisfactory individual pain relief in post-operative pain trials.

Acta anaesthesiologica Scandinavica·2016
Same author

Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Tissue factor activates allosteric networks in factor VIIa through structural and dynamic changes.

Journal of thrombosis and haemostasis : JTH·2014

Inhibiting factor VIIa (FVIIa) with active site inhibitors makes the tissue factor (TF) binding interface more rigid. This structural change occurs specifically where FVIIa’s protease domain interacts with TF.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hemostasis

Background:

  • Activated factor VII (FVIIa) initiates blood clotting by binding to tissue factor (TF).
  • Active site-inhibited FVIIa (FVIIai) exhibits higher affinity for TF than FVIIa.
  • Understanding the structural dynamics of the FVIIa-TF interaction is crucial for hemostasis research.

Purpose of the Study:

  • To compare the interactions of FVIIa and FVIIai with soluble TF (sTF).
  • To investigate the structural consequences of active site inhibition on the FVIIa-TF interface.

Main Methods:

  • Site-directed mutagenesis of six residues in sTF at the FVIIa binding interface.
  • Attachment of fluorescent and spin probes to engineered cysteine residues in sTF.
  • Monitoring changes in hydrophobicity, accessibility, and rigidity within the sTF-FVIIa complex using spectroscopic techniques.

Related Experiment Videos

Main Results:

  • Active site inhibition of FVIIa led to increased rigidity and decreased solvent accessibility in sTF regions interacting with FVIIa's protease domain.
  • The FVIIa active site inhibitor induced a less flexible and more compact interface structure.
  • The interaction interface between sTF and the light chain of FVIIa remained unaffected by active site occupancy.

Conclusions:

  • Active site occupancy in FVIIa significantly alters the structural dynamics of its interface with TF.
  • The findings highlight the role of FVIIa's protease domain in mediating TF binding interface rigidity.
  • This study provides insights into the allosteric regulation of the FVIIa-TF complex.